About this episode

The episode discusses practical approaches to PI3K pathway testing and targeted treatment options for advanced endocrine-resistant breast cancer.

Listen to this conversation between Cristina Saura Manich, MD, PhD, and Giampaolo Bianchini, MD, as they discuss practical approaches to PI3K pathway testing, emerging PI3K and AKT-targeted treatment options, and sequencing therapy for patients with metastatic breast cancer following development of endocrine therapy resistance.

More episodes of Decera Clinical Education Oncology Podcast

• Beyond BCMA: How GPRC5D-Targeted Therapy Fits into Multiple Myeloma Care Today · July 14, 2026 · 27 min
• What Oncology Pharmacists Need to Know About Targeting BCMA in Early Relapsed/Refractory Myeloma · July 13, 2026 · 29 min
• Personalizing EGFR Mutation–Positive NSCLC Care: Strategies for the Advanced Practice Provider · June 22, 2026 · 27 min

Explore listener stats, chart rankings, contacts and more on the Decera Clinical Education Oncology Podcast podcast page.